PROPYLTHIOURACIL TABLETS

phebra canada inc🇨🇦 Health Canada

Approval Id: 6a52f97a1a82e176
Drug Approval Canada Name: PROPYLTHIOURACIL TABLETS
Product Name: PROPYLTHIOURACIL TABLETS
Status: Marketed
Status Date: 2022-07-21
Original Market Date: 2022-07-21
Din: 02523019
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:36.08
Atc Original: H03BA02 PROPYLTHIOURACIL
Atc Name: h 03 ba 02
Aig Number: 0103603001
Company Name: phebra canada inc
Company Address: 216, 7171 Frederick-Banting, Montreal, Quebec, Canada, H4S 1Z9

PROPYLTHIOURACIL

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6a52f97a1a82e176

Type

Standard